These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 10363689

  • 1. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients.
    Onsager DR, Canver CC, Jahania MS, Welter D, Michalski M, Hoffman AM, Mentzer RM, Love RB.
    J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP.
    Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group.
    Mentzer RM, Jahania MS, Lasley RD.
    Transplantation; 1998 Jan 15; 65(1):109-13. PubMed ID: 9448154
    [Abstract] [Full Text] [Related]

  • 5. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 6. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P.
    J Pediatr Surg; 1997 May 15; 32(5):688-90. PubMed ID: 9165452
    [Abstract] [Full Text] [Related]

  • 7. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
    Ciancio G, Burke GW, Suzart K, Roth D, Kupin W, Rosen A, Olson L, Esquenazi V, Miller J.
    Transplantation; 2002 Apr 15; 73(7):1100-6. PubMed ID: 11965039
    [Abstract] [Full Text] [Related]

  • 8. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
    Xenos EX, Ciancio G, Burke GW, Roth D, Miller J.
    Clin Transplant; 1997 Oct 15; 11(5 Pt 2):497-9. PubMed ID: 9361949
    [Abstract] [Full Text] [Related]

  • 9. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J.
    Transplantation; 1996 Sep 15; 62(5):594-9. PubMed ID: 8830821
    [Abstract] [Full Text] [Related]

  • 10. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D, Kribben A, Pietruck F, Lutz J, Binek M, Philipp T, Heemann U, Witzke O.
    Nephron Clin Pract; 2006 Sep 15; 103(3):c94-9. PubMed ID: 16534238
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
    Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart B, Klepetko W.
    J Thorac Cardiovasc Surg; 2003 Apr 15; 125(4):891-900. PubMed ID: 12698153
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
    Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.
    Pediatr Transplant; 1999 Feb 15; 3(1):22-6. PubMed ID: 10359027
    [Abstract] [Full Text] [Related]

  • 13. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
    Herget S, Heemann U, Friedrich J, Kribben A, Wagner K, Philipp T.
    Clin Nephrol; 1996 May 15; 45(5):352-4. PubMed ID: 8738671
    [Abstract] [Full Text] [Related]

  • 14. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO, Barr ML, Radovancevic B, Renlund DG, Mentzer RM, Smart FW, Tolman DE, Frazier OH, Young JB, VanVeldhuisen P.
    J Heart Lung Transplant; 1999 Apr 15; 18(4):336-45. PubMed ID: 10226898
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation.
    Vitulo P, Oggionni T, Cascina A, Arbustini E, D'Armini AM, Rinaldi M, Meloni F, Rossi A, Viganò M.
    J Heart Lung Transplant; 2002 Apr 15; 21(4):435-9. PubMed ID: 11927219
    [Abstract] [Full Text] [Related]

  • 16. Conversion of cyclosporine A to tacrolimus following heart transplantation.
    Mathieu P, Carrier M, White M, Pellerin M, Perrault LP, Pelletier G, Pelletier LC.
    Can J Cardiol; 1999 Nov 15; 15(11):1229-32. PubMed ID: 10579737
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
    Horning NR, Lynch JP, Sundaresan SR, Patterson GA, Trulock EP.
    J Heart Lung Transplant; 1998 Aug 15; 17(8):761-7. PubMed ID: 9730424
    [Abstract] [Full Text] [Related]

  • 18. Management of acute steroid-resistant rejection after liver transplantation.
    Platz KP, Mueller AR, Zytowski M, Lemmens P, Lobeck H, Neuhaus P.
    World J Surg; 1996 Oct 15; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364
    [Abstract] [Full Text] [Related]

  • 19. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC, Pham SM, Seaberg EC, Pappo O, Kormos RL, Kawai A, Griffith BP, Zeevi A, Duquesnoy R, Fung JJ, Starzl TE, Demetris AJ.
    J Heart Lung Transplant; 1997 Jul 15; 16(7):723-34. PubMed ID: 9257254
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus as a rescue immunosuppressant after heart transplantation.
    De Bonis M, Reynolds L, Barros J, Madden BP.
    Eur J Cardiothorac Surg; 2001 May 15; 19(5):690-5. PubMed ID: 11343954
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.